- Resource
- Source: Campus Sanofi
- Sep 4, 2025
556/146 for Lipid Management after ACS
556/146 for Lipid Management after ACS
Gain deeper insights into the innovative concept of 556/146, this project aligns with the ESC/EAS 2019 dyslipidemia guidelines, which recommend that post-ACS (Acute Coronary Syndrome) patients achieve an LDL-C value of less than 55 mg/dL (1.4 mmol/L). Lipid levels should be reassessed 4-6 weeks after an ACS event, and if the target is not met, lipid-lowering treatments should be adjusted accordingly.
Through four comprehensive video episodes, we will explore the importance of these targets and the steps necessary to achieve them.
%20400x300.webp)
Episode #1
A video explaining the concept of 556/146. Featuring all 3 experts: Prof. A. Catapano, Prof. F. Schiele, Prof. A. Zaman.
Episode #2
A video exploring the concept of 556/146. Featuring all 3 experts: Dr. M. Villaceque, Prof. A. Sionis, Prof. R. De Caterina.
Episode #3
A video with focused insights on 556 concept and why it’s important to achieve LDL-C targets for post-ACS patients.
Episode #4
A video with focused insights on 146 concept and why it’s important to re-evaluate lipid levels within 4-6 weeks for post-ACS patients.
MAT-KW-2400310/v1/Sep 2024